Literature DB >> 10780513

Chemotherapy for high-grade gliomas.

E Galanis1, J Buckner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10780513      PMCID： PMC2363368          DOI： 10.1054/bjoc.1999.1075

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  85 in total

1.  Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.

Authors:  J C Buckner; L D Brown; T L Cascino; J B Gerstner; J E Krook; M W Westberg; M Wiesenfeld; J R O'Fallon; B Scheithauer
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

2.  Intravenous carboplatin for recurrent malignant glioma: a phase II study.

Authors:  W K Yung; L Mechtler; M J Gleason
Journal:  J Clin Oncol       Date:  1991-05       Impact factor: 44.544

Review 3.  High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.

Authors:  H A Fine; K H Antman
Journal:  Bone Marrow Transplant       Date:  1992-10       Impact factor: 5.483

4.  Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.

Authors:  T E Elliott; J C Buckner; T L Cascino; R Levitt; J R O'Fallon; B W Scheithauer
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

5.  The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.

Authors:  T Yoneda; R M Lyall; M M Alsina; P E Persons; A P Spada; A Levitzki; A Zilberstein; G R Mundy
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

6.  Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy.

Authors:  D J Sebag-Montefiore; E Douek; J E Kingston; P N Plowman
Journal:  Clin Oncol (R Coll Radiol)       Date:  1992-11       Impact factor: 4.126

7.  Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

Authors:  H A Fine; K B Dear; J S Loeffler; P M Black; G P Canellos
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

8.  The treatment of anaplastic oligodendrogliomas and mixed gliomas.

Authors:  A P Kyritsis; W K Yung; J Bruner; M J Gleason; V A Levin
Journal:  Neurosurgery       Date:  1993-03       Impact factor: 4.654

9.  Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.

Authors:  E H Oldfield; Z Ram; K W Culver; R M Blaese; H L DeVroom; W F Anderson
Journal:  Hum Gene Ther       Date:  1993-02       Impact factor: 5.695

10.  Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.

Authors:  L W Brady; C Miyamoto; D V Woo; M Rackover; J Emrich; H Bender; S Dadparvar; Z Steplewski; H Koprowski; P Black
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038
View more
  25 in total

Review 1.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

2.  [Malignant gliomas--radiotherapy].

Authors:  Annemarie Schratter-Sehn
Journal:  Wien Med Wochenschr       Date:  2006-06

3.  Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.

Authors:  Evanthia Galanis; Jan C Buckner; Matthew J Maurer; Joel M Reid; Mary J Kuffel; Matthew M Ames; Bernd W Scheithauer; Julie E Hammack; George Pipoly; Steven A Kuross
Journal:  Invest New Drugs       Date:  2005-10       Impact factor: 3.850

4.  Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

Authors:  Mateusz Opyrchal; Cory Allen; Ianko Iankov; Ileana Aderca; Mark Schroeder; Jann Sarkaria; Evanthia Galanis
Journal:  Hum Gene Ther       Date:  2012-03-09       Impact factor: 5.695

5.  Astrocytic tumors in children: treatment results from a single institution.

Authors:  Ali Varan; Canan Akyüz; Nejat Akalan; Lale Atahan; Figen Söylemezoglu; Ugur Selek; Bilgehan Yalçin; Tezer Kutluk; Münevver Büyükpamukçu
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

6.  Prediction of the anti-glioma therapeutic effects of temozolomide through in vivo molecular imaging of MMP expression.

Authors:  Li Li; Yang Du; Dehui Xiang; Liang Chen; Zhifeng Shi; Jie Tian; Xinjian Chen
Journal:  Biomed Opt Express       Date:  2018-06-20       Impact factor: 3.732

7.  Convection enhanced delivery of macromolecules for brain tumors.

Authors:  Ankit I Mehta; Bryan D Choi; Divya Ajay; Raghu Raghavan; Martin Brady; Allan H Friedman; Ira Pastan; Darell D Bigner; John H Sampson
Journal:  Curr Drug Discov Technol       Date:  2012-12

8.  Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line.

Authors:  Samideh Khoei; Mohsen Shoja; Ahmad Mostaar; Fariborz Faeghi
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-08

9.  Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study.

Authors:  Mario Balducci; Giuseppe Roberto D'Agostino; Stefania Manfrida; Filippo De Renzi; Gabriella Colicchio; Giuseppina Apicella; Annunziato Mangiola; Alba Fiorentino; Vincenzo Frascino; Giovanna Mantini; Berardino De Bari; Angelo Pompucci; Vincenzo Valentini; Carmelo Anile; Numa Cellini
Journal:  J Neurooncol       Date:  2009-08-25       Impact factor: 4.130

10.  The outcomes of concomitant chemoradiotherapy followed by adjuvant chemotherapy with temozolomide for newly diagnosed high grade gliomas : the preliminary results of single center prospective study.

Authors:  Jung-Won Choi; Min Mi Lee; In Ah Kim; Jee Hyun Kim; Gheeyoung Choe; Chae-Yong Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.